• Canonico, M., Plu-Bureau, G., Lowe, G.D. & Scarabin, P.Y. (2008) Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ, 336, 12271231.
  • Cushman, M., Cornell, E.S., Howard, P.R., Bovill, E.G. & Tracy, R.P. (1995) Laboratory methods and quality assurance in the Cardiovascular Health Study. Clinical Chemistry, 41, 264270.
  • Cushman, M., Psaty, B.M., Meilahn, E.N., Dobs, A.S. & Kuller, L.H. (2001) Post-menopausal hormone therapy and concentrations of protein C and antithrombin in elderly women. British Journal of Haematology, 114, 162168.
  • Cushman, M., Kuller, L.H., Prentice, R., Rodabough, R.J., Psaty, B.M., Stafford, R.S., Sidney, S. & Rosendaal, F.R. (2004a) Estrogen plus progestin and risk of venous thrombosis. Journal of the American Medical Association, 292, 15731580.
  • Cushman, M., Tsai, A.W., White, R.H., Heckbert, S.R., Rosamond, W.D., Enright, P. & Folsom, A.R. (2004b) Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. American Journal of Medicine, 117, 1925.
  • Folsom, A.R., Wu, K.K., Rosamond, W.D., Sharrett, A.R. & Chambless, L.E. (1997) Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation, 96, 11021108.
  • Folsom, A.R., Cushman, M., Tsai, M.Y., Aleksic, N., Heckbert, S.R., Boland, L.L., Tsai, A.W., Yanez, N.D. & Rosamond, W.D. (2002) A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood, 99, 27202725.
  • Folsom, A.R., Golden, S.H., Boland, L.L. & Szklo, M. (2005) Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women. European Journal of Epidemiology, 20, 10151022.
  • Grady, D., Wenger, N.K., Herrington, D., Khan, S., Furberg, C., Hunninghake, D., Vittinghoff, E. & Hulley, S. (2000) Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin replacement study. Annals of Internal Medicine, 132, 689696.
  • Grodstein, F., Stampfer, M.J., Goldhaber, S.Z., Manson, J.E., Colditz, G.A., Speizer, F.E., Willett, W.C. & Hennekens, C.H. (1996) Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet, 348, 983987.
  • Hernán, M.A., Alonso, A., Logan, R., Grodstein, F., Michels, K.B., Willett, W.C., Manson, J.E. & Robins, J.M. (2008) Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology, 19, 766779.
  • Hoibraaten, E., Qvigstad, E., Andersen, T.O., Mowinckel, M.C. & Sandset, P.M. (2001) The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial. Thrombosis and Haemostasis, 85, 775781.
  • Oger, E., Alhenc-Gelas, M., Lacut, K., Blouch, M.T., Roudaut, N., Kerlan, V., Collet, M., Abgrall, J.F., Aiach, M., Scarabin, P.Y. & Mottier, D. (2003) Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 16711676.
  • Ohira, T., Cushman, M., Tsai, M.Y., Zhang, Y., Heckbert, S.R., Zakai, N.A., Rosamond, W.D. & Folsom, A.R. (2007) ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). Journal of Thrombosis and Haemostasis, 5, 14551461.
  • Samama, M.M. (2000) An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Archives of Internal Medicine, 160, 34153420.
  • Simon, T., Beau Yon de Jonage-Canonico, M., Oger, E., Wahl, D., Conard, J., Meyer, G., Emmerich, J., Barrellier, M.T., Guiraud, A. & Scarabin, P.Y. (2006) Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism. Journal of Thrombosis and Haemostasis, 4, 7176.
  • Szklo, M., Cerhan, J., Diez-Roux, A.V., Chambless, L., Cooper, L., Folsom, A.R., Fried, L.P., Knopman, D. & Nieto, F.J. (1996) Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Epidemiology, 144, 10481057.
  • Tsai, A.W., Cushman, M., Rosamond, W.D., Heckbert, S.R., Polak, J.F. & Folsom, A.R. (2002a) Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Archives of Internal Medicine, 162, 11821189.
  • Tsai, A.W., Cushman, M., Rosamond, W.D., Heckbert, S.R., Tracy, R.P., Aleksic, N. & Folsom, A.R. (2002b) Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). American Journal of Medicine, 113, 636642.
  • White, R.H., Zhou, H., Murin, S. & Harvey, D. (2005) Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thrombosis and Haemostasis, 93, 298305.
  • Wilcosky, T.C. & Chambless, L.E. (1985) A comparison of direct adjustment and regression adjustment of epidemiologic measures. Journal of Chronic Diseases, 38, 849856.
  • Yamagishi, K., Cushman, M., Heckbert, S.R., Tsai, M.Y. & Folsom, A.R. (2009) Lack of association of soluble endothelial protein C receptor and PROCR 6936A/G polymorphism with the risk of venous thromboembolism in a prospective study. British Journal of Haematology, 145, 221226.